{
      "brief_title": [
            "monoclonal",
            "antibody",
            "treatment",
            "lymphoma"
      ],
      "brief_summary": [
            "epratuzumab",
            "currently",
            "study",
            "combination",
            "rituximab",
            "treatment",
            "patient",
            "nhl",
            "fail",
            "previous",
            "chemotherapy",
            "never",
            "receive",
            "rituximab",
            "receive",
            "rituximab",
            "single",
            "agent",
            "combination",
            "chemotherapy",
            "last",
            "treatment",
            "demonstrate",
            "partial",
            "response",
            "complete",
            "response",
            "least",
            "12",
            "month"
      ],
      "condition": [
            "lymphoma"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "epratuzumab"
      ],
      "criteria": [
            "diagnosis",
            "relapse",
            "refractory",
            "nhl",
            "receive",
            "fail",
            "least",
            "1",
            "prior",
            "regimen",
            "chemotherapy",
            "receive",
            "prior",
            "rituximab",
            "last",
            "treatment",
            "single",
            "agent",
            "combination",
            "chemotherapy",
            "demonstrate",
            "time",
            "progression",
            "least",
            "12",
            "month"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "mesh_term": [],
      "id": "NCT00044902"
}